CN109678715A - 2-(1-酰氧正戊基)苯甲酸与碱性氨基酸或氨基胍形成的盐、其制备方法及用途 - Google Patents
2-(1-酰氧正戊基)苯甲酸与碱性氨基酸或氨基胍形成的盐、其制备方法及用途 Download PDFInfo
- Publication number
- CN109678715A CN109678715A CN201811440339.8A CN201811440339A CN109678715A CN 109678715 A CN109678715 A CN 109678715A CN 201811440339 A CN201811440339 A CN 201811440339A CN 109678715 A CN109678715 A CN 109678715A
- Authority
- CN
- China
- Prior art keywords
- pentyl
- benzoic acid
- compound
- salt
- oxygen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/12—Acetic acid esters
- C07C69/14—Acetic acid esters of monohydroxylic compounds
- C07C69/145—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols
- C07C69/157—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/26—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing carboxyl groups by reaction with HCN, or a salt thereof, and amines, or from aminonitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C277/08—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/02—Guanidine; Salts, complexes or addition compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/12—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/08—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
- C07C69/24—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with monohydroxylic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/78—Benzoic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Abstract
Description
成分 | 数量(mg/片) |
(S)-2-(1-酰氧正戊基)苯甲酸盐 | 50 |
淀粉 | 30 |
微晶纤维素 | 20 |
硬脂酸镁 | 1 |
羧甲基纤维素钠 | 3 |
成分 | 数量(mg/胶囊) |
(S)-2-(1-酰氧正戊基)苯甲酸盐 | 50 |
淀粉 | 30 |
甲基纤维素 | 5 |
交联PVP | 0.5 |
成分 | 数量 |
(S)-2-(1-酰氧正戊基)苯甲酸盐 | 10mg/瓶 |
注射用水 | 适量 |
注射用氯化钠 | 适量 |
成分 | 数量 |
(S)-2-(1-酰氧正戊基)苯甲酸盐 | 10mg/瓶 |
注射用水 | 适量 |
甘露醇 | 适量 |
Claims (10)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811440339.8A CN109678715B (zh) | 2018-11-28 | 2018-11-28 | 2-(1-酰氧正戊基)苯甲酸与碱性氨基酸或氨基胍形成的盐、其制备方法及用途 |
DK18941434.5T DK3838887T3 (da) | 2018-11-28 | 2018-12-03 | Benzoesyresalt dannet af basisk aminosyre eller aminoguanidin, fremgangsmåde til fremstilling deraf og anvendelser deraf |
JP2021517584A JP7264999B2 (ja) | 2018-11-28 | 2018-12-03 | 2-(1-アシルオキシ-n-ペンチル)安息香酸と塩基性アミノ酸またはアミノグアニジンによって形成される塩と、その製造方法及び用途 |
PCT/CN2018/118879 WO2020107500A1 (zh) | 2018-11-28 | 2018-12-03 | 2-(1-酰氧正戊基)苯甲酸与碱性氨基酸或氨基胍形成的盐、其制备方法及用途 |
MYPI2021001460A MY194645A (en) | 2018-11-28 | 2018-12-03 | 2-(1-acyloxypentyl) benzoic acid salt formed by basic amino acid or aminoguanidine, preparation method therefor and uses thereof |
US17/276,172 US11814352B2 (en) | 2018-11-28 | 2018-12-03 | Salts formed by 2-(1-acyloxy-n-pentyl) benzoic acid and basic amino acid or aminoguanidine, and preparation method and application thereof |
KR1020217011155A KR102563378B1 (ko) | 2018-11-28 | 2018-12-03 | 2-(1-아실옥시-n-펜틸)벤조산 및 염기성 아미노산 또는 아미노구아니딘이 형성하는 염, 이의 제조 방법 및 용도 |
EP18941434.5A EP3838887B1 (en) | 2018-11-28 | 2018-12-03 | 2-(1-acyloxypentyl) benzoic acid salt formed by basic amino acid or aminoguanidine, preparation method therefor and uses thereof |
ES18941434T ES2929539T3 (es) | 2018-11-28 | 2018-12-03 | Sal formada por ácido 2-(1-aciloxipentil) benzoico mediante un aminoácido básico o aminoguanidina, método de preparación y usos de la misma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811440339.8A CN109678715B (zh) | 2018-11-28 | 2018-11-28 | 2-(1-酰氧正戊基)苯甲酸与碱性氨基酸或氨基胍形成的盐、其制备方法及用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109678715A true CN109678715A (zh) | 2019-04-26 |
CN109678715B CN109678715B (zh) | 2019-11-12 |
Family
ID=66185967
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811440339.8A Active CN109678715B (zh) | 2018-11-28 | 2018-11-28 | 2-(1-酰氧正戊基)苯甲酸与碱性氨基酸或氨基胍形成的盐、其制备方法及用途 |
Country Status (9)
Country | Link |
---|---|
US (1) | US11814352B2 (zh) |
EP (1) | EP3838887B1 (zh) |
JP (1) | JP7264999B2 (zh) |
KR (1) | KR102563378B1 (zh) |
CN (1) | CN109678715B (zh) |
DK (1) | DK3838887T3 (zh) |
ES (1) | ES2929539T3 (zh) |
MY (1) | MY194645A (zh) |
WO (1) | WO2020107500A1 (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111943898A (zh) * | 2019-05-17 | 2020-11-17 | 浙江大学 | 苯联四氮唑类衍生物、制备、含其的药物组合物及其应用 |
CN112679353A (zh) * | 2020-12-26 | 2021-04-20 | 郑州大学 | 一种基于丁苯酞结构的前体药物或其药学上可接受的金属盐及其制备方法和应用 |
CN113024422A (zh) * | 2021-03-12 | 2021-06-25 | 中国医学科学院放射医学研究所 | 丁苯酞开环化合物、药物化合物以及它们的制备方法、组合物和应用 |
CN113105326A (zh) * | 2021-03-24 | 2021-07-13 | 海南卓华制药有限公司 | 赖氨匹林的制备方法及应用 |
WO2022095965A1 (zh) * | 2020-11-06 | 2022-05-12 | 浙江大学 | 四氮唑类衍生物、制备、含其的药物组合物及其应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9514518D0 (en) * | 1995-07-15 | 1995-09-13 | Sod Conseils Rech Applic | Guanidine salt inhibitors of NO synthase and cyclooxygenase |
CN1243541C (zh) * | 2002-05-09 | 2006-03-01 | 中国医学科学院药物研究所 | 2-(α-羟基戊基)苯甲酸盐及其制法和用途 |
AU2009340420A1 (en) * | 2008-10-29 | 2010-08-26 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
ES2937386T3 (es) * | 2010-01-27 | 2023-03-28 | Arena Pharm Inc | Procesos para la preparación de ácido (R)-2-(7-(4-ciclopentil-3-(trifluorometil)benciloxi)-1,2,3,4-tetrahidrociclopenta[b]indol-3-il)acético y sales del mismo |
KR102497273B1 (ko) * | 2014-03-06 | 2023-02-07 | 피티씨 테라퓨틱스, 인크. | 1,2,4-옥사디아졸 벤조산의 약학 조성물 및 염 |
JP6838744B2 (ja) * | 2015-06-22 | 2021-03-03 | アリーナ ファーマシューティカルズ, インコーポレイテッド | S1P1レセプター関連障害における使用のための(R)−2−(7−(4−シクロペンチル−3−(トリフルオロメチル)ベンジルオキシ)−1,2,3,4−テトラヒドロシクロペンタ[b]インドール−3−イル)酢酸(化合物1)の結晶性L−アルギニン塩 |
-
2018
- 2018-11-28 CN CN201811440339.8A patent/CN109678715B/zh active Active
- 2018-12-03 JP JP2021517584A patent/JP7264999B2/ja active Active
- 2018-12-03 ES ES18941434T patent/ES2929539T3/es active Active
- 2018-12-03 MY MYPI2021001460A patent/MY194645A/en unknown
- 2018-12-03 WO PCT/CN2018/118879 patent/WO2020107500A1/zh unknown
- 2018-12-03 US US17/276,172 patent/US11814352B2/en active Active
- 2018-12-03 KR KR1020217011155A patent/KR102563378B1/ko active IP Right Grant
- 2018-12-03 DK DK18941434.5T patent/DK3838887T3/da active
- 2018-12-03 EP EP18941434.5A patent/EP3838887B1/en active Active
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111943898A (zh) * | 2019-05-17 | 2020-11-17 | 浙江大学 | 苯联四氮唑类衍生物、制备、含其的药物组合物及其应用 |
WO2022095965A1 (zh) * | 2020-11-06 | 2022-05-12 | 浙江大学 | 四氮唑类衍生物、制备、含其的药物组合物及其应用 |
CN112679353A (zh) * | 2020-12-26 | 2021-04-20 | 郑州大学 | 一种基于丁苯酞结构的前体药物或其药学上可接受的金属盐及其制备方法和应用 |
CN113024422A (zh) * | 2021-03-12 | 2021-06-25 | 中国医学科学院放射医学研究所 | 丁苯酞开环化合物、药物化合物以及它们的制备方法、组合物和应用 |
CN113024422B (zh) * | 2021-03-12 | 2022-12-20 | 上海科州药物研发有限公司 | 丁苯酞开环化合物、药物化合物以及它们的制备方法、组合物和应用 |
CN113105326A (zh) * | 2021-03-24 | 2021-07-13 | 海南卓华制药有限公司 | 赖氨匹林的制备方法及应用 |
Also Published As
Publication number | Publication date |
---|---|
US11814352B2 (en) | 2023-11-14 |
JP7264999B2 (ja) | 2023-04-25 |
DK3838887T3 (da) | 2022-12-05 |
EP3838887A1 (en) | 2021-06-23 |
US20220024848A1 (en) | 2022-01-27 |
MY194645A (en) | 2022-12-09 |
KR20210097100A (ko) | 2021-08-06 |
JP2022503890A (ja) | 2022-01-12 |
WO2020107500A1 (zh) | 2020-06-04 |
CN109678715B (zh) | 2019-11-12 |
EP3838887B1 (en) | 2022-10-05 |
KR102563378B1 (ko) | 2023-08-07 |
ES2929539T3 (es) | 2022-11-30 |
EP3838887A4 (en) | 2022-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109678715B (zh) | 2-(1-酰氧正戊基)苯甲酸与碱性氨基酸或氨基胍形成的盐、其制备方法及用途 | |
CN1243541C (zh) | 2-(α-羟基戊基)苯甲酸盐及其制法和用途 | |
US4070484A (en) | Antiallergic composition containing aromatic carboxylic amide derivatives and method of using the same | |
JP2015524401A (ja) | 置換アミノインダン−およびアミノテトラリンカルボン酸ならびにその使用 | |
WO2016015479A1 (zh) | β-榄香烯13位衍生物及其治疗动脉粥样硬化的用途 | |
JPS62500872A (ja) | 新規なアゾ化合物 | |
AU2019350699A1 (en) | Process of making calcium alpha-ketoglutarate | |
WO2019218864A1 (zh) | 一种2-(α羟基戊基)苯甲酸的有机胺酯衍生物药物 | |
CN108840871B (zh) | 具有抗肿瘤活性的13-羟基金雀花碱肉桂酸酯类化合物及其制备方法 | |
CN108947946A (zh) | 抗脑损伤氘代化合物及其医药用途 | |
CN109956868A (zh) | 一类苯基羧酸衍生物、其制备方法及其用途 | |
CN102344360B (zh) | 精氨酸右旋布洛芬的制备方法 | |
CN102408375B (zh) | 奥扎格雷钠化合物 | |
JPS606355B2 (ja) | 新規アミノ安息香酸誘導体、その製法及び医薬組成物 | |
JP2005529146A (ja) | 中枢神経系障害の治療で使用するための実質的に純粋な固形型3−インドリルピルビン酸のエノール互変異性体 | |
CN112679353B (zh) | 一种基于丁苯酞结构的前体药物或其药学上可接受的金属盐及其制备方法和应用 | |
CN103772355A (zh) | 雷贝拉唑钠化合物 | |
JPS5910563A (ja) | α−(N−ピロリル)−フエニル酢酸誘導体およびその製造方法 | |
CN108997268B (zh) | 基于牛蒡子苷元的化合物、制备方法和用途 | |
SU1015821A3 (ru) | Способ получени моноамидных производных терефталевой кислоты | |
CN117186001A (zh) | 一种具有抗多发性骨髓瘤活性的aha1抑制剂及其制备方法和应用 | |
CN103739618B (zh) | 头孢唑林酯及其制备方法、口服抗生素制剂 | |
JPS59216899A (ja) | 2′―デオキシ―5―トリフルオロメチルウリジン誘導体及びそれを含む抗腫瘍剤 | |
AT387966B (de) | Neue n-1h-tetrazol-5-yl-(5-ring)-carboxamidderivate sowie verwendung derartiger verbindungen | |
KR920004457B1 (ko) | 살리실산의 (-)캄포렌산 에스테르의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230110 Address after: 222000 Jiangning Industrial City, Lianyungang Economic and Technological Development Zone, Jiangsu Province Patentee after: JIANGSU KANION PHARMACEUTICAL Co.,Ltd. Address before: No. 639 Jiangning longmian Road District of Nanjing City, Jiangsu province 211198 Patentee before: CHINA PHARMACEUTICAL University |
|
TR01 | Transfer of patent right | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Yihua Inventor after: Xiao Wei Inventor after: Huang Zhangjian Inventor after: Wu Jianbing Inventor after: Zhu Jiayi Inventor after: Wang Zhenzhong Inventor after: Wang Tuanjie Inventor before: Zhang Yihua Inventor before: Huang Zhangjian Inventor before: Zhu Jiayi |
|
CB03 | Change of inventor or designer information |